NCT06745908
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Registered research study with 5 identifiable England locations. See source dates, location-specific recruitment and the original study record.
Study facts
- Conditions recorded
- NSCLC Stage IV
- Lead sponsor
- ImmunityBio, Inc.
- Study type
- Interventional
- Overall status
- Recruiting · this can differ by location
- Age range in the record
- 18 Years to 90 Years
- Sex eligibility field
- All
- Healthy volunteers accepted
- No, according to the record
- Phase
- Phase3
- Study record last updated
- 27 July 2026
- Study team last verified status
- 2025-10
These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.
England study locations
A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.
| Location in the source | Local recruitment status | Geographic connection |
|---|---|---|
| Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital Truro · TR1 3LJ | Recruiting | Care in Cornwall England postcode |
| Royal London Hospital London · NW3 2QG | Recruiting | Care in Camden England postcode |
| Southampton General Hospital, Southampton University Hospital National Health Service Trust Southampton · SO16 6YD | Recruiting | Care in Southampton England postcode |
| Royal Surrey County Hospital NHS Foundation Trust - St Lukes Cancer Centre Guildford · GU2 7XX | Recruiting | Care in Guildford England postcode |
| University Hospital Birmingham NHS Trust Birmingham · B9 5SS | Recruiting | Care in Birmingham England postcode |
Questions for the research team
- Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
- What visits, tests, possible risks and follow-up would participation involve?
- Are travel costs or accessibility arrangements available?
- How would participation affect my usual care, and what happens if I withdraw?
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
How we selected and connected these records
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.